Search Results

1 - 10 of 44 items :

  • type 2 diabetes mellitus x
Clear All
Flozins, inhibitors of type 2 renal sodium-glucose co-transporter – not only antihyperglycemic drugs

References 1. Bhatia K. et al.: Canagliflozin-current status in the treatment of type 2 diabetes mellitus with focus on clinical trial data. World J. Diabetes, 5, 399, 2014. 2. Chao E., Henry R.: SGLT2 inhibition - a novel strategy for diabetes treatment. Nature Rev. Drug Discov., 9, 551, 2010. 3. Diamant M., Morsink L.: SGLT2 inhibitors for diabetes: turning symptoms into therapy. Lancet, 382, 917, 2013. 4. Endocrine Today. http://www.healio.com/endocrinology/diabetes/(...)sglt2-inhibitors

Open access
The blood resistin level in patients with DM2, depending on the duration of the disease

; 409: 307-12. 17. Tokuyama Y. et al.: Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus. Metabolism, 2007; 56 (5): 693-698. 18. Vozarova De Courten B. et al.: High serum resistin is associated with an increase in adiposity but not worsening of insulin resistance in Pima Indian. Diabetes, 2004; 53 (9): 1279-1284.

Open access
Genetic polymorphisms in diabetes: Influence on therapy with oral antidiabetics

Pro12Ala variant in the PPAR-γ2 gene and the response rate to therapy with pioglitazone in patients with type 2 diabetes, Diabetes Care   26 (2003) 825-831; DOI: 10.2337/diacare.26.3.825. K. H. Zhang, Q. Huang, X. P. Dai, J. Y. Yin, W. Zhang, G. Zhou, H. H. Zhou and Z. Q. Liu, Effects of the peroxisome proliferator activated receptor-γ coactivator-1α (PGC-1α) Thr394Thr and Gly482Ser polymorphisms on rosiglitazone response in Chinese patients with type 2 diabetes mellitus, J. Clin. Pharmacol.   50 (2010) 1022-1030; DOI: 10

Open access
Spirulina maxima and its effect on antioxidant activity in fructose induced oxidative stress with histopathological observations

References [1] Aebi H. Catalase in vitro. In: Colowick S.P., Kalpan, N.O (Eds), Methods in Enzymology, Academic press, 1984, 121-126. [2] American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, Volume 36, Supplement 1, January 2013, S67-S74. [3] Arulselvan P, Subramanian SP. Beneficial effects of Murraya Koenigii leaves on antioxidant defense system and ultra structural changes of pancreatic β-cells in experimental diabetes in rats. Chem Biol Interact. 2007, 165: 155

Open access
Sildenafil alters biogenic amines and increases oxidative damage in brain regions of insulin-hypoglycemic rats

REFERENCES 1. A. V. Raveendran, E. C. Chacko and J. M. Pappachan, Non-pharmacological treatment options in the management of diabetes mellitus, Eur. Endocrinol. 14 (2018) 31–39; https://doi.org/10.17925/EE.2018.14.2.31 2. A. Hussain, O. B. Latiwesh, F. Ali, M. Y. G. Younis and J. A. Alammari, Effects of body mass index, glycemic control, and hypoglycemic drugs on serum uric acid levels in type 2 diabetic patients, Cureus 10 (2018) e3158; https://doi.org/10.7759/cureus.3158 3. G. T. Chen, B. B. Yang, J. H. Chen, Z. Zhang, L. L. Zhu, H

Open access
Qualitative and quantitative HPLC-ELSD-ESI-MS analysis of steroidal saponins in fenugreek seed

Trigonella foenum–graecum and its herbal formulations, J. Planar. Chromatogr. – Mod. TLC 28 (2015) 458–465; https://doi.org/10.1556/1006.2015.28.6.7 23. F. R. Lu, L. Shen, Y. Qin and L. Gao, Clinical observation of Trigonella foenum-graecum saponin combining sulphanylureas on 36 cases of type 2 diabetes mellitus, Chin. J. Integr. Med. 33 (2008) 184–187; https://doi.org/10.1007/s11655-007-9005-3 24. T. Kawabata, M.-Y. Cui, T. Hasegawa, F. Takano and T. Ohta, Anti-inflammatory and anti-melanogenic steroidal saponin glycosides from fenugreek

Open access
Relationship between clinical effectiveness and pharmacoeconomic cost in patients with diabetes mellitus

outcomes, costs and cost effectiveness of interventions in diabetes mellitus (types 1 and types 2) to support clinical and reimbursement decision-making, Curr Med Res Opin 2004, 20 (Suppl1):S5-S26 UK PROSPECTIVE DIABETES STUDY (UKPDS) GROUP. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet 1998, 352, p. 837-853. DRUMMOND M. F. - O BRIEN B. - STODDART G. L, - TORRANCE G. W.: Methods for the

Open access
Antioxidative Activity and Inhibition of Key Enzymes Linked to Type-2 Diabetes (α-Glucosidase and α-Amylase) by Khaya Senegalensis

References 1. International Diabetes Federation: Diabetes Atlas 2011, 5th ed., International Diabetes Federation, Brussels 2011. 2. K. Srinivasan, B. Viswanad, A. Lydia, C. L. Kaul and P. Ramarao, Combination of high-fat diet-fed and low-dose streptozotocin treated rat: A model for type 2 diabetes and pharmacological screening, Pharmacol. Res. 52 (2005) 313-320; DOI: 10.1016/j.phrs.2005.05.004. 3. D. Quilliot, E. Walter, J. P. Bonte, J. C. Fruchart, P. Duriez and O. Ziegler, Diabetes mellitus worsens antioxidant

Open access
Carvedilol and Pycnogenol® improve the function of diabetic hearts in rats

muscle in rats with streptozotocin-induced diabetes mellitus. Acta Diabetol. 2010; 47 (1 suppl):153-159. [7] Grimm D, Jabusch H, Kossmehl P, Huber M, Fredersdorf S, Griese DP, Kramer BK, Kromer EP: Experimental diabetes and left ventricular hypertrophy. Effects of beta-receptor blockade. Cardiovas Pathology.2002;11: 229-237. [8] Goyal BR, Parmar K, Goyal RK, Mehta AA: Beneficial role of telmisartan on cardiovascularcomplications associated with STZ-induced type 2 diabetes in rats. Pharmacol Report. 2011; 63: 956-966. [9

Open access
Potential prophylactic role of aminoguanidine in diabetic retinopathy and nephropathy in experimental animals

. Jiang, J. E. Saavedra, L. K. Keefer, J. A. Hrabie and M. R. Kibbe, Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome, Am. J. Physiol. Heart. Circ. Physiol.   295 (2008) 2388-2398. G. P. Bautista, L. G. Sanchez, C. U. Cristobal, E. Tapia, V. Soto and C. M. Avila, Chronic inhibition of NOS-2 ameliorates renal injury, as well as COX-2 and TGF-beta 1 over expression in 5/6 neprhectomized rats, Nephrol. Diab. Transpl.   21 (2006) 3074-3081. H. J. Han, J. L. Lee, S

Open access